The $850,000 drug whose price tag will surprise Wall Street … for being less than expected Spark Therapeutics’ Luxturna will cost $850,000 for a one-time treatment. The gene therapy treats a rare, inherited retinal disease that can lead to blindness. Spark also unveiled a set of payment and access programs, including tying payments to how … Continue reading Wednesday January 3, 2018